Eligibility Screening of Patients With CNS Tumors for NCI Clinical Research Protocols
-Adult patients (greater than or equal to 18 yrs of age) with tumors of the central nervous
system who are being evaluated by the Neuro-Oncology Branch (NOB) for National Cancer
Institute (NCI) primary research protocols will be entered onto this screening protocol for
- Evaluate patients with tumors of the Central Nervous System (CNS) for eligibility in
National Cancer Institute (NCI) research protocols.
- Patients with tumors of the CNS or a history of a CNS tumor who are being evaluated for
protocols within the National Cancer Institute.
- The screening tests and procedures that are required by the primary research protocols
will be conducted in order to establish eligibility for these protocols.
- These procedures may include, but are not limited to, laboratory tests on blood, CSF,
urine, or other specimens, and radiographic and nuclear medicine studies, which may
require the administration of contrast or a radioisotopic tracer.
- In some cases, specific research samples required for the primary research protocol may
be collected during the screening process in order to prevent us from having to subject
the patient to a painful procedure on multiple occasions (e.g., bone marrow
- Research specimens will be discarded, if the patient is not eligible for or elects not
to enroll on the primary research protocol. A total of 3000 patients will be enrolled.
Teri N Kreisl, M.D.
National Cancer Institute (NCI)
United States: Federal Government
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Bethesda, Maryland 20892|